EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dual Inhibitors of p38α Mitogen-Activated Protein Kinase and Butyrylcholinesterase for the Modulation of Neuroinflammation and Cognitive Dysfunction

Damijan Knez iD, David Malinak iD, Anže Meden iD, Svit Ferjančič Benetik, Anja Pišlar, Zuzana Kohoutova, Iveta Vondrackova, Miroslav Psotka, Antonin Lycka, Lenka Pulkrabkova, Ondrej Soukup iD, Adam Skarka und 15 weitere

Journal of Medicinal Chemistry · 2026

DOI: 10.1021/acs.jmedchem.6c01461 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2026. Verfasst von Damijan Knez und 26 weiteren Autor:innen. Beteiligte Einrichtung: University of Ljubljana , Faculty of Pharmacy, 1000Ljubljana, Slovenia. Hauptthemen laut MEDLINE: Butyrylcholinesterase, Mitogen-Activated Protein Kinase 14, Cognitive Dysfunction, Neuroinflammatory Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministarstvo za visoko ?olstvo, znanost in inovacije Republike Slovenije, The Slovenian Research and Innovation Agency, Univerza v Ljubljani.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic neuroinflammation and cholinergic dysfunction are major contributors to cognitive decline in Alzheimer’s disease. Here, we report a series of pyridazine-based multitarget-directed ligands that simultaneously inhibit human butyrylcholinesterase (hBChE) and p38α mitogen-activated protein kinase (p38α MAPK). Pyridazines 8 and 21 were identified as potent dual inhibitors with submicromolar inhibitory potencies against target enzymes and high selectivity over acetylcholinesterase. X-ray crystallographic analyses revealed the experimental binding modes of 8 and 21 in hBChE and p38α MAPK, and identified conserved π–π, π–cation, and hinge region interactions that rationalize dual-target engagement. Both compounds were blood-brain barrier permeable, exhibited low cytotoxicity, and significantly attenuated lipopolysaccharide-induced proinflammatory responses and apoptosis in BV2 microglia. In vivo, compound 21 enhanced cognitive performance in mouse models of scopolamine-induced amnesia and LPS-stimulated neuroinflammatory cognitive impairment. Collectively, these results document the potential of structure-assisted design to achieve selective dual-target pharmacology within a single molecular entity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ButyrylcholinesteraseMitogen-Activated Protein Kinase 14Cognitive DysfunctionNeuroinflammatory DiseasesCholinesterase InhibitorsPyridazinesProtein Kinase InhibitorsAnimalsHumansMiceStructure-Activity RelationshipCrystallography, X-RayLipopolysaccharidesMicrogliaAmnesiaCognitive EnhancementMaleModels, Molecular

Substanzen

ButyrylcholinesteraseMitogen-Activated Protein Kinase 14Cholinesterase InhibitorsPyridazinesLipopolysaccharidesProtein Kinase Inhibitors

Autor:innen und Institutionen

  • University of Ljubljana , Faculty of Pharmacy, 1000Ljubljana, Slovenia.
  • University Hospital in Hradec Kralove, Biomedical Research Centre, 500 05Hradec Kralove, Czech Republic.
  • University of Hradec Kralove, Faculty of Science, Department of Chemistry, 500 03Hradec Kralove, Czech Republic.
  • Département de Toxicologie et Risques Chimiques, Institut de Recherche Biomédicale des Armées, Brétigny-sur-Orge91220, France.
  • Department of Pharmacodynamics, Chair of Pharmacodynamics, Faculty of Pharmacy, Jagiellonian University Medical College, Krakow30-688, Poland.
  • Department of Pharmacology, Northwestern University, Chicago, Illinois60611, United States.

ORCID-Profile: Damijan Knez, David Malinak, Anže Meden, Ondrej Soukup, José Dias, Florian Nachon, Joseph S Brunzelle, Saktimayee Mitra Roy, Daniel Martin Watterson, Stanislav Gobec

Förderung

  • Ministarstvo za visoko ?olstvo, znanost in inovacije Republike Slovenije
  • The Slovenian Research and Innovation Agency
  • Univerza v Ljubljani
  • Univerzita Hradec Kr?lov?
  • Ministerstvo Zdravotnictv? Cesk? Republiky
  • NIA NIH HHS
  • European Regional Development Fund
  • Grantov? Agentura Cesk? Republiky

Zitieren

APA

Knez, D., Malinak, D., Meden, A., Ferjančič Benetik, S., Pišlar, A., Kohoutova, Z., Vondrackova, I., Psotka, M., Lycka, A., Pulkrabkova, L., Soukup, O., Skarka, A., Andrys, R., Brazzolotto, X., Igert, A., Dias, J., Nachon, F., Detka, J., Targosiński, F., …, & Gobec, S. (2026). Dual Inhibitors of p38α Mitogen-Activated Protein Kinase and Butyrylcholinesterase for the Modulation of Neuroinflammation and Cognitive Dysfunction. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c01461

Vancouver

Knez D, Malinak D, Meden A, Ferjančič Benetik S, Pišlar A, Kohoutova Z, et al. Dual Inhibitors of p38α Mitogen-Activated Protein Kinase and Butyrylcholinesterase for the Modulation of Neuroinflammation and Cognitive Dysfunction. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.6c01461

BibTeX
@article{Knez2026,
  author = {Knez, Damijan and Malinak, David and Meden, Anže and Ferjančič Benetik, Svit and Pišlar, Anja and Kohoutova, Zuzana and Vondrackova, Iveta and Psotka, Miroslav and Lycka, Antonin and Pulkrabkova, Lenka and Soukup, Ondrej and Skarka, Adam and Andrys, Rudolf and Brazzolotto, Xavier and Igert, Alexandre and Dias, José and Nachon, Florian and Detka, Jan and Targosiński, Filip and Hliabovich, Dziyana and Brunzelle, Joseph S and Shuvalova, Ludmilla and Sałat, Kinga and Roy, Saktimayee Mitra and Watterson, Daniel Martin and Musílek, Kamil and Gobec, Stanislav},
  title = {Dual Inhibitors of p38α Mitogen-Activated Protein Kinase and Butyrylcholinesterase for the Modulation of Neuroinflammation and Cognitive Dysfunction},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  doi = {10.1021/acs.jmedchem.6c01461}
}
Kostenlos starten →